Tumor immunotherapy using gene-modified human mesenchymal stem cells loaded into synthetic extracellular matrix scaffolds.
about
Immunotherapeutic organoids: a new approach to cancer treatmentMesenchymal stem cells modified with a single-chain antibody against EGFRvIII successfully inhibit the growth of human xenograft malignant gliomaBalanced secretion of anti-CEA × anti-CD3 diabody chains using the 2A self-cleaving peptide maximizes diabody assembly and tumor-specific cytotoxicity.Antitumor Activity of a Mesenchymal Stem Cell Line Stably Secreting a Tumor-Targeted TNF-Related Apoptosis-Inducing Ligand Fusion Protein.Exploitation of herpesvirus immune evasion strategies to modify the immunogenicity of human mesenchymal stem cell transplants.Genetic modification of mesenchymal stem cells to express a single-chain antibody against EGFRvIII on the cell surface.Different culture conditions modulate the immunological properties of adipose stem cells.Concise review: stem cells as an emerging platform for antibody therapy of cancer.Design of "smart" probes for optical imaging of apoptosis.Hyaluronic acid hydrogels for biomedical applications.The therapeutic potential of engineered human neovessels for cell-based gene therapy.Hyaluronic acid-based clinical biomaterials derived for cell and molecule delivery in regenerative medicine.Non-hematopoietic stem cells as factories for in vivo therapeutic protein production.Bioluminescence imaging: progress and applicationsAdvances in stem cells, induced pluripotent stem cells, and engineered cells: delivery vehicles for anti-glioma therapy.In situ production of therapeutic monoclonal antibodies.Engineering Stem Cells for Biomedical Applications.Cryogel-supported stem cell factory for customized sustained release of bispecific antibodies for cancer immunotherapy.Characterization of the Tumor Microenvironment and Tumor-Stroma Interaction by Non-invasive Preclinical ImagingMesenchymal stem cells: A new platform for targeting suicide genes in cancer.Lentivirus-modified human umbilical cord mesenchymal stem cells maintain their pluripotency.T Cell-Activating Mesenchymal Stem Cells as a Biotherapeutic for HCC.Engineered Mesenchymal Cells Improve Passive Immune Protection Against Lethal Venezuelan Equine Encephalitis Virus Exposure.Improved anti-leukemia activities of adoptively transferred T cells expressing bispecific T-cell engager in miceIn vivo secretion of anti-CD3 × anti-tumor bispecific antibodies by gene-modified cells: over a decade of T-cell engagement.Functional comparison of single-chain and two-chain anti-CD3-based bispecific antibodies in gene immunotherapy applications.Factory neovessels: engineered human blood vessels secreting therapeutic proteins as a new drug delivery system.ATTACK, a novel bispecific T cell-recruiting antibody with trivalent EGFR binding and monovalent CD3 binding for cancer immunotherapy.Intranasal delivery of stem cell-based therapies for the treatment of brain malignancies.Targeting delivery of lipocalin 2-engineered mesenchymal stem cells to colon cancer in order to inhibit liver metastasis in nude mice.
P2860
Q26853431-6FBAC511-8B14-4959-9E68-2063B69E9924Q28473229-005675E4-2F8C-4D4C-8A93-55F1E2ADB816Q33600768-D270D84B-9219-4873-953A-F858FEEA05D6Q33658976-CBA5F0B0-3A4C-4986-984A-30430E6CFA82Q33799067-581CF6CA-FBA2-4FEB-9325-75F63BE6B439Q33892058-DF25B444-28A8-4D59-A1D1-2923642A77A4Q34273076-48E7B09B-B6FE-4B67-BDBB-0C7D2A476FA6Q34414838-9858596D-1F46-4D2A-A6D6-574C73766266Q35891172-481CC358-19E4-4730-913D-146906FCDFF9Q37063026-52E6CD85-2BBC-4A01-A618-8693726D445CQ37809876-DCB7A1C9-0A93-468B-981B-DC86DBB70B9FQ37868075-80052262-5FF8-4E55-AF52-E57AB3F1BC76Q37874445-E9195479-A452-45F3-B7D1-913E1E179AD4Q37905334-5434BBC9-9AC8-4698-98A0-E56B12F19709Q38227489-30A4B6CE-F36A-4568-9D74-50FC7DDC2BD6Q38314210-4264AD56-E524-493C-B785-A20FD10C81B8Q38378499-1F50C1C8-E39D-458A-95BC-5C6A53B28C85Q38756773-061630A8-65B5-4D0A-9B44-BB94228B7E1AQ39135714-F5A7D573-D35F-49BF-8F3E-446EACCD3E80Q39432344-322894D5-61CE-42F8-B589-1E7999A279C1Q39766924-E493C81D-8095-4055-B68B-20392BBC9D39Q40064011-6D554466-AB98-4AAB-9963-ED1261036806Q40686919-3C874006-B0E9-455C-8E5E-53E7C37972BFQ41879726-C94145BC-4E0C-4E38-8CF0-EE2D407C92E5Q42560301-49C7DC7C-27AC-43D1-9F3E-74E3CA3B81D1Q42729764-8075D73A-849D-4858-99FA-23319380B40BQ45857985-ED1F8692-B4B1-465A-B446-A010BF1715C4Q47138591-3A831479-F65F-4A32-95AD-8E5E1567C2C7Q48117495-98533168-7494-4B2F-83D8-3BDFF22C8796Q51001958-C52B8530-B201-4BF3-BF50-9AA1EAB4A089
P2860
Tumor immunotherapy using gene-modified human mesenchymal stem cells loaded into synthetic extracellular matrix scaffolds.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scienca artikolo
@eo
scientific article published on March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
name
Tumor immunotherapy using gene ...... xtracellular matrix scaffolds.
@en
Tumor immunotherapy using gene ...... xtracellular matrix scaffolds.
@nl
type
label
Tumor immunotherapy using gene ...... xtracellular matrix scaffolds.
@en
Tumor immunotherapy using gene ...... xtracellular matrix scaffolds.
@nl
prefLabel
Tumor immunotherapy using gene ...... xtracellular matrix scaffolds.
@en
Tumor immunotherapy using gene ...... xtracellular matrix scaffolds.
@nl
P2093
P2860
P50
P1433
P1476
Tumor immunotherapy using gene ...... extracellular matrix scaffolds
@en
P2093
Angel M Cuesta
José Luís Vicario
Laura Sanz
Vanesa Alonso-Camino
P2860
P304
P356
10.1634/STEMCELLS.2008-0831
P577
2009-03-01T00:00:00Z